Compare COMBAT DRUGS with - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DECIPHER LABS vs BHARAT PARENTALS - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DECIPHER LABS BHARAT PARENTALS DECIPHER LABS/
BHARAT PARENTALS
 
P/E (TTM) x 27.6 12.1 227.9% View Chart
P/BV x 6.2 1.9 321.8% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 DECIPHER LABS   BHARAT PARENTALS
EQUITY SHARE DATA
    DECIPHER LABS
Mar-21
BHARAT PARENTALS
Mar-21
DECIPHER LABS/
BHARAT PARENTALS
5-Yr Chart
Click to enlarge
High Rs41514 8.0%   
Low Rs18135 13.3%   
Sales per share (Unadj.) Rs55.0357.1 15.4%  
Earnings per share (Unadj.) Rs1.435.5 3.9%  
Cash flow per share (Unadj.) Rs2.246.0 4.8%  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs13.6250.3 5.4%  
Shares outstanding (eoy) m10.105.73 176.3%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x0.50.9 59.1%   
Avg P/E ratio x21.39.2 232.4%  
P/CF ratio (eoy) x13.47.1 190.2%  
Price / Book Value ratio x2.21.3 168.1%  
Dividend payout %00-   
Avg Mkt Cap Rs m2981,860 16.0%   
No. of employees `000NANA-   
Total wages/salary Rs m473148 320.9%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m5562,046 27.2%  
Other income Rs m687 7.4%   
Total revenues Rs m5622,133 26.3%   
Gross profit Rs m35252 13.8%  
Depreciation Rs m860 13.6%   
Interest Rs m128 152.9%   
Profit before tax Rs m21271 7.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m768 10.9%   
Profit after tax Rs m14203 6.9%  
Gross profit margin %6.312.3 50.9%  
Effective tax rate %34.525.1 137.6%   
Net profit margin %2.59.9 25.4%  
BALANCE SHEET DATA
Current assets Rs m2251,480 15.2%   
Current liabilities Rs m173436 39.7%   
Net working cap to sales %9.451.0 18.5%  
Current ratio x1.33.4 38.4%  
Inventory Days Days7788 86.8%  
Debtors Days Days7661,210 63.3%  
Net fixed assets Rs m161506 31.9%   
Share capital Rs m10157 176.3%   
"Free" reserves Rs m361,377 2.6%   
Net worth Rs m1371,434 9.5%   
Long term debt Rs m6786 78.1%   
Total assets Rs m3871,987 19.5%  
Interest coverage x2.836.5 7.8%   
Debt to equity ratio x0.50.1 819.0%  
Sales to assets ratio x1.41.0 139.5%   
Return on assets %6.710.6 62.7%  
Return on equity %10.214.2 72.3%  
Return on capital %16.218.3 88.5%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m0534 0.0%   
Fx outflow Rs m0247 0.0%   
Net fx Rs m0287 0.0%   
CASH FLOW
From Operations Rs m18313 5.9%  
From Investments Rs m-3-479 0.7%  
From Financial Activity Rs m4083 48.3%  
Net Cashflow Rs m55-84 -65.4%  

Share Holding

Indian Promoters % 0.0 74.4 -  
Foreign collaborators % 45.9 0.0 -  
Indian inst/Mut Fund % 0.0 0.0 -  
FIIs % 0.0 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 54.1 25.6 211.3%  
Shareholders   12,796 2,912 439.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DECIPHER LABS With:   SUN PHARMA    LUPIN    CIPLA    AUROBINDO PHARMA    DR. REDDYS LAB    



Today's Market

Jubilant FoodWorks' Stock Split, Delhivery's Rs 76.4 bn IPO, and Buzzing Stocks Today(Pre-Open)

Indian share markets ended on a flat note on Friday. Benchmark indices snapped their four-day winning run and ended lower amid weak global cues.

Related Views on News

Sun Pharma vs Dr Reddy's: Which is Better? (Views On News)

Dec 16, 2021

In an extremely competitive market, two pharma companies are competing against each other to grab the top spot.

5 Stocks to Watch Out for Amid the Omicron Outbreak (Views On News)

Dec 3, 2021

As the new variant of Covid-19 emerges, keep an eye on these stocks.

This Stock Just Made a Historical Debut on the Exchanges (Views On News)

Nov 15, 2021

Shares of the company listed at premium of 253% from its IPO price, the highest ever.

3 Indian Pharma Companies that are Investing Big Time for the Future (Views On News)

Nov 9, 2021

In 2021, R&D of pharma companies roared to life in a never-before-seen way.

Demerger of Financial & Pharma Businesses puts Piramal Enterprises in Limelight (Views On News)

Oct 8, 2021

The company's shareholders will be issued 4 shares in the demerged entity for every 1 held in Piramal Enterprises.

More Views on News

Most Popular

India's Best Semiconductor Stocks(Views On News)

Jan 7, 2022

Modern wars are fought with semiconductors. India's best semiconductor stocks have big tailwinds from defence and manufacturing.

10 Indian Companies with the Fastest Growth in Dividend Payouts...(Views On News)

Jan 10, 2022

These companies have been consistently paying higher dividends for several years.

Tata Steel vs SAIL: Which Stock is Better?(Views On News)

Jan 13, 2022

With government initiatives set to boost the steel sector, find out who has a better chance of coming out on top.

Looking for Consistent Compounding Stocks? Here's a Watchlist for You(Views On News)

Jan 6, 2022

These companies have generated mind boggling returns for investors over the years.

My Best Sectors for 2022(Fast Profits Daily)

Jan 4, 2022

My top 2 sectors for 2022 might surprise you.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

DECIPHER LABS SHARE PRICE


Jan 14, 2022 (Close)

TRACK DECIPHER LABS

  • Track your investment in DECIPHER LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

DECIPHER LABS 8-QTR ANALYSIS

COMPARE DECIPHER LABS WITH

MARKET STATS